Xtant Medical Holdings (XTNT) Enterprise Value (2010 - 2025)

Xtant Medical Holdings (XTNT) has 16 years of Enterprise Value data on file, last reported at -$17.3 million in Q4 2025.

• On a quarterly basis, Enterprise Value fell 178.54% year-over-year to -$17.3 million in Q4 2025; TTM through Dec 2025 was -$17.3 million, a 178.54% decrease from a year earlier, with the FY2025 full-year figure at -$17.3 million, down 178.54% from the prior year.
• Enterprise Value for Q4 2025 stood at -$17.3 million, down from -$10.6 million in the prior quarter.
• Over the last five years, Enterprise Value for XTNT reached as high as -$4.4 million in Q2 2023 and fell as low as -$20.5 million in Q2 2021.
• Historically, Enterprise Value has averaged -$11.8 million across 5 years, with a median of -$9.7 million in 2023.
• Across the five-year window, Enterprise Value sank 685.43% in 2021 and jumped 73.6% in 2023, its largest moves.
• Year by year, Enterprise Value stood at -$18.4 million in 2021, then decreased by 11.53% to -$20.5 million in 2022, then surged by 71.12% to -$5.9 million in 2023, then dropped by 5.03% to -$6.2 million in 2024, then tumbled by 178.54% to -$17.3 million in 2025.
• Per Business Quant data, the three most recent Enterprise Value figures were -$17.3 million in Q4 2025, -$10.6 million in Q3 2025, and -$7.0 million in Q2 2025.